Profil Financier
Timothy Springer occupe actuellement le rang #1579 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $2.6 B (-$310 sur 24h).
Timothy Springer is an immunologist and professor of biological chemistry and molecular pharmacology at Harvard Medical School.
He was a founding investor in publicly traded biotech outfit Moderna, investing about $5 million in 2010; he now owns an estimated 3% of the firm's shares.
Springer also owns shares of three smaller publicly traded biotech firms: Cartesian Therapeutics, Scholar Rock and Tectonic Therapeutic.
He first started teaching at Harvard in 1977 as an assistant professor.
In 1993, he founded biotech firm LeukoSite and took it public in 1998; the next year, he sold it to Millennium Therapeutics for $635 million.
In 2017, Springer established the Institute for Protein Innovation, an independent nonprofit focused on researching proteins, with an initial grant of $10 million.
Springer bikes to work from his home in Chestnut Hill, Massachusetts.